SIBEPRENLIMAB
UNII GHX28QZ7DD

Substance Identification & Data

This profile provides standardized clinical and technical data for Sibeprenlimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) GHX28QZ7DD.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2382896-07-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

GHX28QZ7DD

CAS Registry Number

2382896-07-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

SIBEPRENLIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

GHX28QZ7DD

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C179120

National Cancer Institute reference terminology for clinical and research data.

INN ID

11575

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

KL-40

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Sibeprenlimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

SIBEPRENLIMAB

SIBEPRENLIMAB-SZSI

Common Names & Synonyms

IMMUNOGLOABULIN G2-KAPPA, ANTI-(HOMO SAPIENS TNFSF13 (TUMOR NECROSIS FACTOR (TNF) SUPERFAMILY MEMBER 13, APRIL, CD256)), HUMANIZED MONOCLONAL ANTIBODY; GAMMA2 HEAVY CHAIN HUMANIZED (1-446) (VH (HOMO SAPIENS IGHV1-46*01 (85.7%) -(IGHD) -IGHJ4*01 (100%)) CDR-IMGT (8.8.13) (26-33.51-58.97-109) (1-120) -HOMO SAPIENS IGHG2*01 (100%), G2M.. CH2 V45.1 (CH1 (121-218), HINGE 1-12 (219-230), CH2 V45.1 (281) (231-339), CH3 (340-444), CHS (445-446)) (121-446)), (134-218')-DISULFIDE WITH KAPPA LIGHT CHAIN HUMANIZED (1'-218') (V-KAPPA (HOMO SAPIENS IGKV3-15*01 (85.9%) -IGKJ4*01 (100%)) CDR-IMGT (10.3.9) (27-36.54-56.93-101) (1'-111') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (157), V101 (195) (112'-218')); DIMER (222-222'':223-223'':226-226:229-229)-TETRAKISDISULFIDE, PRODUCED IN A CHINESE HAMSTER OVARY (CHO)-K1 DERIVED CELL LINE, GLYCOFORM ALFA

IMMUNOGLOBULIN G2, ANTI-(HUMAN PROLIFERATION-INDUCING LIGAND PROTEIN) (HUMAN MONOCLONAL VIS649 .GAMMA.2-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL VIS649 .KAPPA.-CHAIN, DIMER

SIBEPRENLIMAB [INN]

SIBEPRENLIMAB [USAN]

SIBEPRENLIMAB [WHO-DD]